Shilpa Medicare Ltd share price logo

Shilpa Medicare Ltd Share Price (SHILPAMED)


Get free price alerts. Set up your Free investment account to get Live Prices. >
Q1 '23 Results
News and Events

Overview of Shilpa Medicare Ltd

Key events for Shilpa Medicare Ltd

  • Shilpa Medicare Receives Regulatory Approvals for Meniere's Syndrome Drug - 04 Sep, 2023

    Shilpa Medicare Ltd has received marketing authorization from the Medicines and Healthcare Products Regulatory Agency (MHRA), UK, for Betahistine Dihydrochloride Orodispersible Films. The company also successfully completed an inspection by Japan’s Pharmaceuticals and Medical Devices Agency. Shilpa is the first company to receive approval for the 24 mg strength as a film formulation in the UK.

  • Shilpa Medicare Receives Approval for Pemetrexed Injections - 01 Aug, 2023

    Shilpa Medicare Limited has received approval from CDSCO to manufacture and sell Pemetrexed Ready to Use injections in India under the brand name VRTU.

  • Shilpa Medicare's Balance Sheet Poses Risk to Business - 17 Jul, 2023

    Shilpa Medicare Ltd has a net debt of about ₹7.74b, with liabilities totaling ₹7.75b more than its cash and short-term receivables. Shareholders face high net debt to EBITDA ratio (7.6) and weak interest coverage, making the debt burden substantial.

  • Shilpa Medicare Stock Surges on Positive News - 30 Jun, 2023

    Shilpa Medicare Ltd's stock jumps 15.7% on high volumes as HNIs buy shares and anticipate a corporate development. Additionally, the company's subsidiary, Shilpa Biologicals, received marketing authorization for its Adalimumab injection.

  • Shilpa Medicare Ltd board to evaluate rights issue proposal - 21 Jun, 2023

    Pharmaceutical company Shilpa Medicare is considering a rights issue of equity shares. The US FDA classified its Hyderabad unit as Voluntary Action Indicated (VAI) in late May, which is a relief for the company at a time when scrutiny from the US drug regulator is leading to delays in key launches for several pharmaceutical companies.

  • Shilpa Medicare Ltd stock jumps 13.56% amid heavy volumes - 20 Jun, 2023

    Shares of Shilpa Medicare Ltd surged by 13.56% to hit a day high of Rs 272.95 over its previous close of Rs 240.35 amid heavy volumes. The company reported a net loss of Rs 8 crore in Q4 FY23, compared to a net profit of Rs 29.50 crore during the same period last year due to tax outflow. However, the stock has an average target price of Rs 292, suggesting a potential upside of 9.67%. Support on the counter could be seen at Rs 255.

Shilpa Medicare Ltd share Performance

  • ₹350.65
    downward going graph



    Day's Volatility:4.95%



    downward going graph
  • ₹222.6
    downward going graph



    52 Weeks Volatility:47.17%



    downward going graph
1 Month Return-3.67 %
3 Month Return23.36 %
1 Year Return-3.69 %
Previous Close₹350.65
Market Cap₹3,043.71Cr

Shilpa Medicare Ltd Company Information

Shilpa Medicare Limited (SML) was established in 1987 and converted to a public limited company in 1993. They are one of the leading API and formulations manufacturers, with expertise in oncology and non-oncology medicines, with over 44 APIs and 16 injectable dosage forms and 19 oral solid dosage forms. SML deploy sophisticated technology in order to comply with international standards. In 2015, funds were raised by allotting 1.76 Mn equity shares at Rs. 423/ share, and in 2016, the face value of equity shares was split into two equity shares of Rs.1/ each. Raichem Medicare Pvt. Ltd., a subsidiary of SML successfully installed all machinery and recruited personnel. During FY16, they launched generic versions of Vidaza Injection and Xeloda Tablets. In 2017, Navya Biologicals Private Limited was acquired and in 2019, they invested Rs 22.71 cr in Shilpa Therapeutics Pvt. Ltd and disinvested 24% stake in Raichem Medicare Pvt. Ltd. In 2021, they launched a pediatric dose paracetamol oral thin film, Molshil and acquired stake in FTF Pharma Pvt. Ltd, Koanaa Healthcare Canada, etc. In 2022, they approved Slump sale of Active Pharmaceutical Ingredient API Business to Shilpa Pharma Lifesciences Limited.

Share Price: ₹358.60 per share as on 29 Sep, 2023 04:01 PM
Market Capitalisation: ₹3,043.71Cr as of today
Revenue: ₹265.73Cr as on March 2023 (Q1 23)
Net Profit: ₹-8.04Cr as on March 2023 (Q1 23)
Listing date: 03 Dec, 2009
Chairperson Name: Omprakash Inani
OrganisationShilpa Medicare Ltd
E-voting on sharesClick here to vote

Fundamentals of Shilpa Medicare Ltd

Insights on Shilpa Medicare Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.


    Retail Holding Up

    Retail Investor have increased holdings from 35.71% to 39.37% in Jun 2023 quarter


    Revenue Rich

    Revenue is up for the last 2 quarters, 265.56 Cr → 265.73 Cr (in ₹), with an average increase of 0.1% per quarter

  • imgNO EFFECT

    Against Peers

    In the last 1 year, Dr Reddys Laboratories Ltd has given 24.5% return, outperforming this stock by 28.2%

  • imgNO EFFECT

    Against Peers

    In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 123.7% return, outperforming this stock by 161.6%

  • imgNO EFFECT

    Promoter Holding Unchanged

    Promoters holdings remained unchanged at 50.01% of holdings in Jun 2023 quarter


    FII Holding Down

    Foreign Institutions have decreased holdings from 13.74% to 10.26% in Jun 2023 quarter


    Profit Down

    Netprofit is down for the last 2 quarters, -6.62 Cr → -8.04 Cr (in ₹), with an average decrease of 21.5% per quarter


    Price Dip

    In the last 3 years, SHILPAMED stock has moved down by -37.9%

Shilpa Medicare Ltd share Valuation

Shilpa Medicare Ltd in the last 5 years

  • Overview

  • Trends

Lowest (-100.97x)

September 7, 2023

Today (-94.77x)

September 28, 2023

Industry (47.79x)

September 28, 2023

Highest (503.73x)

February 21, 2023


Mutual Fund Holdings

Funds Holdings
Motilal Oswal Nifty Microcap 250 Index Fund Direct GrowthMotilal Oswal Nifty Microcap 250 Index Fund Direct Growth0.37%

Shilpa Medicare Ltd Shareholding Pattern

InvestorsHoldings %Prev. 2 periods3M change
Promoter Holdings
Foreign Institutions
Mutual Funds
Retail Investors

Technicals of Shilpa Medicare Ltd share

News & Events of Shilpa Medicare Ltd

QnA on Shilpa Medicare Ltd

  • QuestionAsked on: 11 Apr, 2023

    Why did Shilpa Medicare share price rose 10% on Tuesday (11th April 2023)?

    QnA Result : 12 Apr, 2023User Profile Icon1603 people participated in the quiz

    Shilpa Medicare share price jumped around 10% as the company received approval from the US drug regulator for its psoriatic arthritis drug to be sold in US.

    66.44% of INDmoney users answered correctly

    Management change
    Approval to its arthritis drug in US
    66.44%blue tick
    Won a big order in UK

Frequently Asked Questions

Shilpa Medicare Ltd (SHILPAMED) share price today is ₹358.6

  • Today’s highest price of Shilpa Medicare Ltd is ₹368.4.
  • Today’s lowest price of Shilpa Medicare Ltd is ₹350.65.

Today’s traded volume of Shilpa Medicare Ltd(SHILPAMED) is 3.11L.

Today’s market capitalisation of Shilpa Medicare Ltd(SHILPAMED) is ₹3043.71Cr.

Shilpa Medicare Ltd(SHILPAMEDPrice
52 Week High
52 Week Low

Shilpa Medicare Ltd(SHILPAMED) share price is ₹358.6. It is down -8.46% from its 52 Week High price of ₹391.75

Shilpa Medicare Ltd(SHILPAMED) share price is ₹358.6. It is up 61.10% from its 52 Week Low price of ₹222.6

Shilpa Medicare Ltd(SHILPAMEDReturns
1 Day Returns
1 Month Returns
3 Month Returns
1 Year Returns